FDA relied on proprietary company data, charges Pfizer

Share this article:
Pfizer's charge that the FDA relied on proprietary company data on its Genotropin in approving rival Sandoz' human growth hormone product Omnitrope have been denied by the agency. It said Sandoz had to establish that "Omnitrope is highly similar to Genotropin without reference to proprietary data in Pfizer's Genotropin NDA."
Share this article:

Email Newsletters

More in News

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.

Amgen Q2 sales rise, company to lay off up to 2,900

Amgen Q2 sales rise, company to lay off ...

The majority of the layoffs will be in the US.

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...